[HTML][HTML] The treatment of heart failure with reduced ejection fraction

D Berliner, A Hänselmann… - Deutsches Ärzteblatt …, 2020 - ncbi.nlm.nih.gov
… types of heart failure depending on left ventricular ejection fraction (LVEF) (table 1) (2).
All types of heart failure are associated with a reduction in stroke volume and cardiac output. …

Adherence-adjustment in placebo-controlled randomized trials: an application to the candesartan in heart failure randomized trial

EJ Murray, BL Claggett, B Granger, SD Solomon… - Contemporary Clinical …, 2020 - Elsevier
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular
systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative …

Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)

AG Evdokimova, RI Stryuk, VV Evdokimov… - Consilium …, 2021 - journals.eco-vector.com
candesartan, high adherence to this drug in patients with arterial hypertension, chronic heart
failure, impaired … The advantages of candesartan in comparison with other representatives …

Population pharmacokinetics of candesartan in patients with chronic heart failure

I Kassem, S Sanche, J Li, G Bonnefois… - Clinical and …, 2021 - Wiley Online Library
… Briefly, patients with symptomatic HF (left ventricular ejection fraction ≤ 40% … low-clearance
subgroup of individuals, a candesartan concentration comparable to that of other patients

[HTML][HTML] Effect of candesartan treatment on echocardiographic indices of cardiac remodeling in post-myocardial infarction patients

H Tezcan, A Tunçez, K Demir, BB Altunkeser… - Revista da Associação …, 2023 - SciELO Brasil
… , candesartan group showed significant reduction of estimated left ventricular mass and left
ventricular … safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J …

… during adjuvant breast cancer therapy (PRADA): extended follow-up of a 2× 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and …

SL Heck, A Mecinaj, AH Ree, P Hoffmann… - Circulation, 2021 - Am Heart Assoc
… blocker candesartan attenuated the reduction in left ventricular … in cardiac troponins. This
study aimed to assess the long-term … with candesartan developed symptomatic heart failure. …

[HTML][HTML] Medical management of patients with heart failure and reduced ejection fraction

B Greenberg - Korean circulation journal, 2022 - synapse.koreamed.org
… the Candesartan in Heart Failure Assessment of Reduction in … intolerant patients were
randomized to either candesartan (at a … , heart transplant or need for left ventricular assist device) …

Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial

S Ito, H Takahama, M Asakura, Y Abe, M Ajioka… - Scientific reports, 2023 - nature.com
chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and
chronic heart failure … With the special contribution of the Heart Failure Association (HFA) of …

… hypertension and coronary artery disease: A sub‐analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease

N Kikuchi, H Ogawa… - The Journal of …, 2020 - Wiley Online Library
… serious comorbidities such as heart failure and CAD were … patients had higher prevalence
of multi-vessel CAD, chronic … , such as advanced age and left ventricular dysfunction. Further …

Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction

ER Cosentino, D Degli Esposti, R Miceli… - Current Medical …, 2019 - Taylor & Francis
… In accordance with the current recommendations, left ventricular ejection fraction (LVEF)
was … The mean dose of ramipril and candesartan before switch to sacubitril/valsartan was 5.5 …